In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Piper Sandler analyst Scott Siefers maintained a Buy rating on Citigroup (C – Research Report) today and set a price target of $83.00. The ...

Barclays PLC raised its position in shares of Piper Sandler Companies by 307.2% in the 3rd quarter. Barclays PLC now owns 32,328 shares of the financial services provider’s stock worth $ ...

The Hain Celestial Group (NASDAQ:HAIN – Get Free Report) had its price objective decreased by analysts at Piper Sandler from ...

Fintel reports that on January 6, 2025, Goldman Sachs downgraded their outlook for Piper Sandler Companies (NYSE:PIPR) from ...

But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. Long term Piper Sandler Companies (NYSE:PIPR) shareholders would be well aware ...

View Piper Sandler Companies (PIPR) current and estimated P/E ratio data provided by Seeking Alpha.

Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm, has been navigating a dynamic financial landscape with strategic moves and solid performance.

LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...